Slide 1The Health Strategies Consultancy The Intersection of Business Strategy and Public Policy Prescription Drugs in Medicaid: Past Trends and Future Challenges Jonathan…

Slide 1 The Growing Health Care Crisis in the United States Slide 2 Why do we say that there is a health care crisis in America today? Health Care Crisis Slide 3 I.The United…

Slide 1 Status Report: Medicaid Preferred Drug List Program and Maximum Allowable Cost (MAC) Pricing Presentation to: Senate Finance Committee Health & Human Resources…

Slide 1 Status Report: Medicaid Preferred Drug List Program Presentation to the: Joint Commission on Health Care Behavioral Health Subcommittee Patrick W. Finnerty, Director…

Evaluation of Virginia’s Preferred Drug List: 2nd Quarter Interim Report Policy and Research Division June 22, 2004 Department of Medical Assistance Services Presentation…

February 18, 2013 Artia Advisor 2-13-13 Artia Advisor 2-13-13 On Monday, January 14, the Department of Health and Human Services (HHS) released a 472- page proposed rule…

Evaluation of Virginia’s Preferred Drug List: 2nd Quarter Interim Report Policy and Research Division June 22, 2004 Department of Medical Assistance Services Presentation…

Medicaid Fee-for-Service: Prior Authorization Criteria & the Role of the DUR Board Charles Agte, Pharmacy Administrator Health Care Services June 19, 2013 Statutory Basis…

PowerPoint Presentation ACA Update Part 1: New Rules and Regulations Federal AIDS Policy Partnership August 7, 2013 Andrea Weddle, Co-chair HIV Health Care Access Working…

Governorâs Office of Health Policy and Finance MaineCare Pharmacy Initiatives PDL Preferred Drugs: By definition are usually Cost-Effective Provide the best clinical outcome…